Drug repurposing is a strategy focused on identifying new therapeutic applications for existing drugs. This approach may significantly shorten the time needed to develop new therapies while reducing the costs of clinical research. However, the authors of a recent publication emphasize that studies involving drugs used for new indications require a specific methodological and ethical framework.

We are proud to share a new publication: Dialogue matters. Exploring Deaf people’s research experiences in Poland. This article describes the experiences and opinions of Deaf people on participating in research and scientific enterprise, pointing to the need to ensure accessibility of the research process and broader dialogue between scientists and the Deaf community.

Our team is proud to share a new publication: “Precisely Imprecise: Therapeutic Misconception in Precision Oncology Trials”. The article investigates how the language of precision medicine in cancer trials can shape expectations and sometimes create misunderstandings about personalized treatments. It offers insights into ethical challenges and calls for clearer communication in clinical research.

We are pleased to announce that, by Resolution No. 12/IV/2025 of the Health Sciences Discipline Council of the Jagiellonian University dated December 17, 2025, Katarzyna Klaś was awarded the degree of Doctor in the discipline of Health Sciences.

In October, Tomasz completed an internship at the Amsterdam University Medical Center (Amsterdam UMC), organized as part of the project “Teaching-Engagement-Development (TED): Academic Teachers and Doctoral Students Facing the Challenges of the Future.”